How does sublingual administration of amfexa (immediate‑release dextroamphetamine) alter its duration of action compared with standard oral dosing? | Rounds How does sublingual administration of amfexa (immediate‑release dextroamphetamine) alter its duration of action compared with standard oral dosing? | Rounds
Loading...

How does sublingual administration of amfexa (immediate‑release dextroamphetamine) alter its duration of action compared with standard oral dosing?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2026 · View editorial policy

Sublingual Amfexa (Immediate-Release Dextroamphetamine) Duration of Action

Published clinical pharmacology sources do not provide dosing-route-specific evidence showing a change in the duration of action of Amfexa (immediate-release dextroamphetamine) when given sublingually versus standard oral immediate-release dosing.

For standard oral immediate-release dextroamphetamine, the duration of action is approximately 4 to 6 hours, with a time to peak plasma concentration (Tmax) of about 3 hours. [1]

Key Clinical Comparison: Oral Immediate-Release Reference Duration

  • Oral immediate-release dextroamphetamine duration of action: ~4–6 hours. [1]
  • Oral immediate-release dextroamphetamine Tmax: ~3 hours. [1]

Evidence Gap for Sublingual Administration

  • No authoritative, route-specific pharmacokinetic or pharmacodynamic data were located that quantify duration-of-effect after sublingual Amfexa compared with oral immediate-release dosing. (Inference based on absence of route-specific evidence in the retrieved pharmacology references.) [1]

Related Questions